Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-25 @ 4:42 AM
NCT ID:
NCT06661018
Eligibility Criteria:
Inclusion Criteria:
* Age \> 21 - 80 years
* Agree to participate in the study
* Patients with a diagnosis of Acute Myocardial Infarction with ST-Segment Elevation (AMI-STE) with onset \< 12 hours who underwent primary percutaneous coronary intervention (PCI)
* Successful primary PCI on the culprit lesion (residual stenosis \< 20%, TIMI flow III)
* Received standard medication therapy according to guidelines (Guideline-Directed Medical Therapy; GDMT) achieved during hospitalization
* Sinus rhythm at the time of echocardiographic examination
Exclusion Criteria:
* Patients who routinely consume CoQ10 prior to the study
* Patients with hemodynamic conditions of Killip class III-IV and NYHA class III-IV
* Patients with a history of previous acute myocardial infarction
* Patients with a history of previous PCI or fibrinolytic therapy
* Patients with a history of previous coronary artery bypass surgery
* Patients with heart valve disease greater than moderate severity
* Patients receiving warfarin therapy
* Patients with a diagnosis of isolated right ventricular infarction
* Patients with inadequate echocardiographic image quality (poor echo window)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
80 Years
Study:
NCT06661018
Study Brief:
Protocol Section:
NCT06661018